Literature DB >> 8154502

Elevated Lp(a) levels in patients with end-stage renal disease.

J Thillet, C Doucet, B Issad, M Allouache, J M Chapman, C Jacobs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8154502     DOI： 10.1016/s0272-6386(12)80389-1

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  2 in total

1.  IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans.

Authors:  Nike Müller; Dominik M Schulte; Kathrin Türk; Sandra Freitag-Wolf; Jochen Hampe; Rainald Zeuner; Johann O Schröder; Ioanna Gouni-Berthold; Heiner K Berthold; Wilhelm Krone; Stefan Rose-John; Stefan Schreiber; Matthias Laudes
Journal:  J Lipid Res       Date:  2015-02-21       Impact factor: 5.922

Review 2.  Beyond Lipoprotein(a) plasma measurements: Lipoprotein(a) and inflammation.

Authors:  Gissette Reyes-Soffer; Marit Westerterp
Journal:  Pharmacol Res       Date:  2021-05-23       Impact factor: 10.334
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.